These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4176775)

  • 1. In vitro autoradiographic study of the endometrium from women treated with low-dose chlormadinone acetate for contraception.
    Márquez-Monter H; Funes F; Aznar R; Giner-Velázquez J; Martínez-Manautou J
    Am J Obstet Gynecol; 1968 Nov; 102(6):896-900. PubMed ID: 4176775
    [No Abstract]   [Full Text] [Related]  

  • 2. DNA synthesis in the endometrium of progesterone-treated mice.
    Martin L; Finn CA; Trinder G
    J Endocrinol; 1973 Feb; 56(2):303-7. PubMed ID: 4703243
    [No Abstract]   [Full Text] [Related]  

  • 3. [Morphology and histochemistry of the human endometrium under treatment with continous microdoses of chlormadinone. I. In the spontaneous cycle].
    Antonio Sereno J; Vázquez E; García G
    Ginecol Obstet Mex; 1970 Feb; 27(160):213-8. PubMed ID: 4191102
    [No Abstract]   [Full Text] [Related]  

  • 4. Antifertility effects in the rabbit by continuous low release of progestin from an intrauterine device.
    Vickery BH; Erickson GI; Bennett JP; Mueller NS; Haleblian JK
    Biol Reprod; 1970 Oct; 3(2):154-62. PubMed ID: 4108370
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of a sequential oral contraceptive on endometrial enzyme and carbohydrate histochemistry.
    Hester LL; Kellett WW; Spicer SS; Williamson HO; Pratt-Thomas HR
    Am J Obstet Gynecol; 1968 Nov; 102(6):771-83. PubMed ID: 4176774
    [No Abstract]   [Full Text] [Related]  

  • 6. Chlormadinone acetate 0-5 mg. A report on its effectiveness in continuous use as an oral contraceptive.
    Christie GA
    Med J Aust; 1969 Jul; 2(4):185-9. PubMed ID: 4184973
    [No Abstract]   [Full Text] [Related]  

  • 7. [Morphology and histochemistry of the human endometrium after prolonged administration of 0.5 mg. chlormadinone acetate].
    Maqueo M; García G; Medina del Campo JJ
    Ginecol Obstet Mex; 1970 Mar; 27(161):371-5. PubMed ID: 4191764
    [No Abstract]   [Full Text] [Related]  

  • 8. Daily progestogen for contraception: a clinical study.
    Martinez-Manautou J; Giner-Velasquez J; Cortes-Gallegos V; Aznar R; Rojas B; Guitterez-Najar A; Rudel HW
    Br Med J; 1967 Jun; 2(5554):730-2. PubMed ID: 4164963
    [No Abstract]   [Full Text] [Related]  

  • 9. Contraception with low dose chlormadinone acetate. Clinical and histological results.
    Kühne D; Göretzlehner G; Seidl ST
    Acta Eur Fertil; 1970 Mar; 2(1):75-84. PubMed ID: 4141558
    [No Abstract]   [Full Text] [Related]  

  • 10. Diffusion of progestogens through Silastic rubber implants.
    Lifchez AS; Scommegna A
    Fertil Steril; 1970 May; 21(5):426-30. PubMed ID: 4101385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of switching with oral contraceptives.
    Wassef SA; Sami G; Hamid EA
    Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):77-93. PubMed ID: 12254511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous progestogen contraception: a dose relationship study with chlormadinone acetate.
    Martinez-Manautou J; Giner-Velasquez J; Rudel H
    Fertil Steril; 1967; 18(1):57-61. PubMed ID: 4163467
    [No Abstract]   [Full Text] [Related]  

  • 13. [10 years of research using steroids as controllers of ovulation].
    Martínez-Manautou J
    Gac Med Mex; 1968 Dec; 98(12):1560-75. PubMed ID: 4182066
    [No Abstract]   [Full Text] [Related]  

  • 14. Conversion of 20 alpha-hydroxy-4-pregnen-3-one to progesterone by human endometrium in vitro.
    Maeyama M; Nakahara K; Sudo I; Mori N
    J Steroid Biochem; 1973 Sep; 4(5):457-66. PubMed ID: 4131400
    [No Abstract]   [Full Text] [Related]  

  • 15. The histopathology of the endometrium: selected topics.
    Ober SB; Labay GR
    Obstet Gynecol Annu; 1972; 1():373-420. PubMed ID: 4130219
    [No Abstract]   [Full Text] [Related]  

  • 16. Low-dose continuous chlormadinone acetate as an oral contraceptive. A clinical trial.
    Howard G; Blair M; Elstein M; Morris NF
    Lancet; 1969 Jul; 2(7610):24-6. PubMed ID: 4182794
    [No Abstract]   [Full Text] [Related]  

  • 17. Our experience with sequential estrogen-progestin treatments to inhibit ovulation.
    Cittadini E; Quartararo P; Romano F
    Int J Fertil; 1969; 14(2):180-7. PubMed ID: 4181574
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of mucopolysaccharides and lysosomal hydrolases in endometrial regression following withdrawal of estradiol and chlormadinone acetate. I. Epithelium and stroma.
    Smith RE; Henzl MR
    Endocrinology; 1969 Jul; 85(1):50-66. PubMed ID: 4182327
    [No Abstract]   [Full Text] [Related]  

  • 19. Chlormadinone acetate as an oral contraceptive.
    Rao AP
    J Obstet Gynaecol India; 1970 Oct; 20(5):735-41. PubMed ID: 12254495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial safety of a novel monophasic combined oral contraceptive containing 0.02 mg ethinylestradiol and 2 mg chlormadinone acetate administered in a 24/4-day regimen over six cycles.
    Rabe T; Hartschuh E; Wahlstrom T; Höschen K; König S
    Contraception; 2010 Oct; 82(4):358-65. PubMed ID: 20851230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.